Clinical Trials
5,356 trialsA Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors
University of California, San Diego
Spanish Meaning-Centered Psychotherapy for Cancer
University of Valencia
Nutrition Intervention Trials in Linxian Follow-up Study
National Institutes of Health Clinical Center (CC)
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Developing the Family Map: Looking at Communal Coping
National Institutes of Health Clinical Center (CC)
POM MM 014
Celgene
Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer
National Institutes of Health Clinical Center (CC)
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
National Institutes of Health Clinical Center (CC)
PIPO
Vall d'Hebron Institute of Oncology
ARMOR
University of California, San Francisco
Bright IDEAS - Young Adults Problem-Solving Skills Training
Rutgers, The State University of New Jersey
Supportive Oncology Care at Home Post-Discharge
Massachusetts General Hospital
Evaluation of Abridge Ambient AI Technology Regarding Provider Burnout and Patient Satisfaction With the Clinical Encounter
University of Washington
Virtual Reality Education for Radiation Therapy Patients
Asia University
CEICS
Chulabhorn Cancer Center
Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases
National Institutes of Health Clinical Center (CC)
Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy
Lyvgen Biopharma Holdings Limited
Phase 1 Trial of LVGN7409 (CD40 Agonist Antibody) as Single Agent and Combination Therapies in Advanced or Metastatic Malignancy
Lyvgen Biopharma Holdings Limited
Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction
Barretos Cancer Hospital
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Children's Oncology Group
Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia
Servier
ELEVATE
University of Southampton
Meraki_Cancer
University of Valencia
Laughter Yoga Effect on Cancer Patients' Physiopsychological Symptoms
Ataturk University
Social Media Posts About Cancer: Five Timepoints
UNC Lineberger Comprehensive Cancer Center
ULTIMO
Cancer Research Antwerp
THYSU
University Hospital, Bordeaux
MISOGLIO
University Hospital, Bordeaux
CAPADOGE
University Hospital, Bordeaux
ACTION
Dana-Farber Cancer Institute
CAPARFI
University Hospital, Bordeaux
Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients
Trishula Therapeutics, Inc.
Endometrial Cell Collection With the PadKit
Hackensack Meridian Health
CAERES
UniDistance Suisse
PanRAF
Royal Marsden NHS Foundation Trust
HAPIN
Emory University
PM14 Administered Intravenously to Patients With Advanced Solid Tumors
PharmaMar
Construal Level as a Novel Pathway for Affect Regulation and Cancer Control
University of Oregon
Problem-Solving Therapy for Cancer Caregivers in Outpatient Palliative Care
Washington University School of Medicine
EMPOwer
University of Alberta
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
National Institutes of Health Clinical Center (CC)
Feasibility Neurocognitive Outcome After Transplant
Stanford University
SPiReL
Sunnybrook Health Sciences Centre
NOVEL
Imperial College London
DINING
H. Lee Moffitt Cancer Center and Research Institute
AMPLE-3
The University of Western Australia
CUPem
Imperial College London
CABOTHYROID
Grupo Espanol de Tumores Neuroendocrinos
NUTRI-NURSE-VN
VinUniversity